A Study Evaluating Dosing Regimens for Treatment With Intravitreal Ranibizumab Injections in Subjects With Macular Edema Following Retinal Vein Occlusion
Clinical trial NCT01277302 · COMPLETED
Trial details
- NCT number
- NCT01277302
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2011-02-01
- Primary completion
- 2012-10-01
- Enrollment
- 202
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.